Metformin for Type 2 diabetes mellitus
- PMID: 38661224
- DOI: 10.1111/acem.14922
Metformin for Type 2 diabetes mellitus
Keywords: diabetes; metformin.
References
REFERENCES
-
- Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK prospective Diabetes study (UKPDS) group. Lancet. 1998;352(9131):854‐865.
-
- Boussageon R, Supper I, Bejan‐Angoulvant T, et al. Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta‐analysis of randomised controlled trials. PLoS Med. 2012;9(4):e1001204. doi:10.1371/journal.pmed.1001204
-
- Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355(23):2427‐2443. doi:10.1056/NEJMoa066224
-
- Shi Q, Nong K, Vandvik PO, et al. Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta‐analysis of randomised controlled trials. BMJ. 2023;381:e074068. doi:10.1136/bmj-2022-074068
-
- Gnesin F, Thuesen ACB, Kähler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020;6:CD012906. doi:10.1002/14651858.CD012906.pub2
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
